Calliditas Therapeutics AB (CALT)
21.63
-0.40
(-1.82%)
USD |
NASDAQ |
May 17, 16:00
21.63
0.00 (0.00%)
After-Hours: 20:00
Calliditas Therapeutics Price to Book Value: 17.91 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 17, 2024 | 17.91 |
May 16, 2024 | 17.78 |
May 15, 2024 | 17.86 |
May 14, 2024 | 18.23 |
May 13, 2024 | 16.96 |
May 10, 2024 | 16.57 |
May 09, 2024 | 16.40 |
May 08, 2024 | 16.59 |
May 07, 2024 | 16.65 |
May 06, 2024 | 16.24 |
May 03, 2024 | 16.14 |
May 02, 2024 | 15.33 |
May 01, 2024 | 16.09 |
April 30, 2024 | 16.09 |
April 29, 2024 | 15.05 |
April 26, 2024 | 15.74 |
April 25, 2024 | 15.69 |
April 24, 2024 | 14.93 |
April 23, 2024 | 14.69 |
April 22, 2024 | 14.59 |
April 19, 2024 | 15.09 |
April 18, 2024 | 14.24 |
April 17, 2024 | 15.12 |
April 16, 2024 | 14.36 |
April 15, 2024 | 15.29 |
Date | Value |
---|---|
April 12, 2024 | 15.33 |
April 11, 2024 | 16.57 |
April 10, 2024 | 17.36 |
April 09, 2024 | 18.16 |
April 08, 2024 | 17.36 |
April 05, 2024 | 17.45 |
April 04, 2024 | 17.82 |
April 03, 2024 | 17.15 |
April 02, 2024 | 17.15 |
April 01, 2024 | 16.95 |
March 28, 2024 | 16.95 |
March 27, 2024 | 17.34 |
March 26, 2024 | 17.63 |
March 25, 2024 | 17.62 |
March 22, 2024 | 17.15 |
March 21, 2024 | 17.59 |
March 20, 2024 | 17.19 |
March 19, 2024 | 16.95 |
March 18, 2024 | 17.79 |
March 15, 2024 | 17.99 |
March 14, 2024 | 18.12 |
March 13, 2024 | 18.70 |
March 12, 2024 | 17.81 |
March 11, 2024 | 17.95 |
March 08, 2024 | 17.83 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.743
Minimum
Nov 01 2021
24.09
Maximum
Dec 26 2023
7.662
Average
6.039
Median
Jun 15 2021
Price to Book Value Benchmarks
DBV Technologies SA | 1.005 |
Cellectis SA | 2.540 |
Adaptimmune Therapeutics PLC | 11.64 |
Akari Therapeutics PLC | -- |
Biodexa Pharmaceuticals Plc | 0.8756 |
Price to Book Value Related Metrics
PS Ratio | 4.382 |
Price | 21.63 |
Earnings Yield | -4.43% |
Market Cap | 595.49M |